Lg. Rider et al., A BROADENED SPECTRUM OF JUVENILE MYOSITIS - MYOSITIS-SPECIFIC AUTOANTIBODIES IN CHILDREN, Arthritis and rheumatism, 37(10), 1994, pp. 1534-1538
Objective. Myositis-specific autoantibodies (MSA) define relatively ho
mogenous clinical and immunogenetic patient groups in adults with idio
pathic inflammatory myopathies (IIM). This study explores the usefulne
ss of MSA in defining groups of children with myositis. Methods. Sera
from 77 children with myositis and other connective tissue diseases we
re tested for MSA by immunoprecipitation and immunodiffusion. Clinical
data were collected and analyzed. Results. The MSA anti-PL-12 (alanyl
-transfer RNA synthetase), anti-Jo-1 (histidyl-tRNA synthetase), anti-
signal recognition particle, and anti-Mi-2 were each identified in the
sera of 12 children with IIM. In these patients, the clinical manifes
tations, disease courses, and responses to therapy closely resembled t
hose in adults with the same autoantibodies. Conclusion. These observa
tions suggest that the clinical syndromes defined by particular MSA ar
e similar in children and adults with IIM. By defining similar clinica
l syndromes in children who have MSA, this study provides a basis for
future studies of MSA in the idiopathic inflammatory myopathies of chi
ldhood, which may be useful in predicting the clinical courses of a su
bset of these patients and improving their therapy.